Keros Therapeutics Inc (KROS)

Cost of Revenue

$798.00K

TTM · Period ending: · USD

KROS logo

KROS Cost of Revenue

Latest reported$798.00K
KROS TTM Cost of Revenue ($4.13M → $798.00K)
High-resolution chart · PNG

KROS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
798,000
1,168,000
765,000
1,097,000
1,016,000
646,000
646,000
314,000
551,000
551,000
551,000
551,000
0
0
0
302,000
302,000
10,285,000
10,285,000
9,983,000
9,983,000
0
0
4,130,000
4,130,000
4,130,000
4,130,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.